Emerging strategies and translational advancements of DDR1 in oncology

Abstract Discoidin domain receptor 1 (DDR1) has emerged as a promising therapeutic target in oncology due to its unique role in tumor-stroma interactions and its involvement in key signaling pathways that drive cancer progression. DDR1 is homologous to the transmembrane receptor tyrosine kinase (RTK...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Yuxi Luo, Tianxin Liu, Jinli Pei, Shengnan Xu, Jie Liu, Jinming Yu
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Springer 2025-03-01
Edice:	Discover Oncology
Témata:	Discoidin domain receptor Tyrosine kinase Therapeutic target Drug discovery Oncology
On-line přístup:	https://doi.org/10.1007/s12672-025-02107-z
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!